Chronic Heroin Self-Administration Desensitizes μ Opioid Receptor-Activated G-Proteins in Specific Regions of Rat Brain

作者: Laura J. Sim-Selley , Dana E. Selley , Leslie J. Vogt , Steven R. Childers , Thomas J. Martin

DOI: 10.1523/JNEUROSCI.20-12-04555.2000

关键词: Opioid receptorPeriaqueductal grayMorphineCannabinoidInternal medicineGTPgammaSOpioidEndocrinologyμ-opioid receptorChemistry(+)-NaloxoneGeneral Neuroscience

摘要: In previous studies from our laboratory, chronic noncontingent morphine administration decreased mu opioid receptor-activated G-proteins in specific brainstem nuclei. the present study, receptor binding and were examined after heroin self-administration. Rats trained to self-administer intravenous for up 39 d, achieving intake 366 mg. kg(-1). d(-1). opioid-stimulated [(35)S]GTPgammaS [(3)H]naloxone autoradiography performed adjacent brain sections. Agonist-stimulated also other G-protein-coupled receptors, including delta opioid, ORL-1, GABA(B), adenosine A(1), cannabinoid, 5-HT(1A). brains self-administering rats, was observed periaqueductal gray, locus coeruleus, lateral parabrachial nucleus, commissural nucleus tractus solitarius, as previously morphine-treated animals. addition, found thalamus amygdala Despite this decrease mu-activated G-proteins, demonstrated increased several regions self-administration, there a significant G-protein efficiency expressed ratio between agonist-activated binding. No effects on agonist-stimulated any examined. The effect of self-administration mu-stimulated varied highest lowest cortex striatum. These results not only provide potential neuronal mechanisms that may contribute tolerance dependence, but explain why various opioids develop different degrees.

参考文章(51)
Stefan R. Nahorski, John R. Traynor, Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells Molecular Pharmacology. ,vol. 47, pp. 848- 854 ,(1995)
LJ Sim, DE Selley, SI Dworkin, SR Childers, Effects of chronic morphine administration on mu opioid receptor-stimulated [35S]GTPgammaS autoradiography in rat brain. The Journal of Neuroscience. ,vol. 16, pp. 2684- 2692 ,(1996) , 10.1523/JNEUROSCI.16-08-02684.1996
EJ Nestler, Molecular mechanisms of drug addiction. The Journal of Neuroscience. ,vol. 12, pp. 2439- 2450 ,(1992) , 10.1523/JNEUROSCI.12-07-02439.1992
Bryen A. Jordan, Lakshmi A. Devi, G-protein-coupled receptor heterodimerization modulates receptor function Nature. ,vol. 399, pp. 697- 700 ,(1999) , 10.1038/21441
C E Inturrisi, J G Umans, Pharmacodynamics of subcutaneously administered diacetylmorphine, 6-acetylmorphine and morphine in mice. Journal of Pharmacology and Experimental Therapeutics. ,vol. 218, pp. 409- 415 ,(1981)
Liza Leventhal, Gavril W. Pasternak, Wendy Su, Grace C. Rossi, Jessica Cole, Richard J. Bodnar, Ying-Xin Pan, Antisense mapping of MOR-1 in rats: distinguishing between morphine and morphine-6beta-glucuronide antinociception. Journal of Pharmacology and Experimental Therapeutics. ,vol. 281, pp. 109- 114 ,(1997)
J T Williams, M J Christie, R A North, Cellular mechanisms of opioid tolerance: studies in single brain neurons. Molecular Pharmacology. ,vol. 32, pp. 633- 638 ,(1987)
Laura J. Sim, Ruoyu Xiao, Steven R. Childers, Identification of opioid receptor-like (ORL1) peptide-stimulated [35S]GTPγS binding in rat brain Neuroreport. ,vol. 7, pp. 729- 733 ,(1996) , 10.1097/00001756-199602290-00012